[1]
“Erratum for: Anti-Helicobacter pylori treatment can effectively improve the clinical remission rates of irritable bowel syndrome: a controlled clinical trial meta-analysis”, Clinics, vol. 76, p. e1857err, Nov. 2021, doi: 10.6061/clinics/2021/e1857err.